Recap: Fusion Pharmaceuticals Q4 Earnings

Fusion Pharmaceuticals FUSN reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Fusion Pharmaceuticals missed estimated earnings by -15.0%, reporting an EPS of $-0.39 versus an estimate of $-0.34.

Revenue was down $140 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 2.0% drop in the share price the next day.

Here's a look at Fusion Pharmaceuticals's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.40 -0.39 -0.32 -0.56
EPS Actual -0.25 -0.38 -0.45 -0.55
Revenue Estimate 110K 80K 8.57M 20K
Revenue Actual 2.01M 34K 28K 140K

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Fusion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!